133 related articles for article (PubMed ID: 16083628)
1. [Treatment of hyperhomocysteinemia and endothelial dysfunction in renal-transplant recipients with vitamin B].
Xu T; Wang XF; Qu XK; Ye HY; Huang XB; Zhang XP; Hou SK
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(14):940-3. PubMed ID: 16083628
[TBL] [Abstract][Full Text] [Related]
2. Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients.
Marcucci R; Zanazzi M; Bertoni E; Rosati A; Fedi S; Lenti M; Prisco D; Castellani S; Abbate R; Salvadori M
Transplantation; 2003 May; 75(9):1551-5. PubMed ID: 12792513
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of the effect of treatment of hyperhomocysteinemia and its relationship with inflammation, coagulation status, and endothelial function after renal transplantation.
Manrique J; Diáz A; Gavira JJ; Hernández A; Pujante D; Errasti P
Transplant Proc; 2005 Nov; 37(9):3782-4. PubMed ID: 16386537
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine-lowering therapy and carotid intima-media thickness in renal transplant recipients.
Marcucci R; Zanazzi M; Bertoni E; Rosati A; Fedi S; Lenti M; Prisco D; Castellani S; Abbate R; Salvadori M
Transplant Proc; 2005; 37(6):2491-2. PubMed ID: 16182720
[TBL] [Abstract][Full Text] [Related]
6. Effects of multivitamins and low-dose folic acid supplements on flow-mediated vasodilation and plasma homocysteine levels in older adults.
Carlsson CM; Pharo LM; Aeschlimann SE; Mitchell C; Underbakke G; Stein JH
Am Heart J; 2004 Sep; 148(3):E11. PubMed ID: 15389247
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hyperhomocysteinemia and endothelial dysfunction in renal transplant recipients with B vitamins in the Chinese population.
Xu T; Zhang XW; Qu XK; Ye HY; Huang XB; Zhang XP; Hou SK; Wang XF
J Urol; 2008 Mar; 179(3):1190-4. PubMed ID: 18206175
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
[TBL] [Abstract][Full Text] [Related]
10. Effect of folic acid on endothelial function following acute myocardial infarction.
Moens AL; Claeys MJ; Wuyts FL; Goovaerts I; Van Hertbruggen E; Wendelen LC; Van Hoof VO; Vrints CJ
Am J Cardiol; 2007 Feb; 99(4):476-81. PubMed ID: 17293188
[TBL] [Abstract][Full Text] [Related]
11. Plasma homocysteine levels in renal transplant patients on tacrolimus therapy.
Akbas SH; Tuncer M; Gurkan A; Yucetin L; Yavuz A; Demirbas A; Ersoy F; Gultekin M; Yakupoglu G; Akaydin M
Transplant Proc; 2004; 36(1):159-60. PubMed ID: 15013332
[TBL] [Abstract][Full Text] [Related]
12. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia in liver transplant recipients: prevalence and multivariate analysis of predisposing factors.
Herrero JI; Quiroga J; Sangro B; Beloqui O; Pardo F; Cienfuegos JA; Prieto J
Liver Transpl; 2000 Sep; 6(5):614-8. PubMed ID: 10980061
[TBL] [Abstract][Full Text] [Related]
14. Effect of fortified spread on homocysteine concentration in apparently healthy volunteers.
van Vliet T; Jacobs RG; de Deckere E; van den Berg H; de Bree A; van der Put NM
Eur J Clin Nutr; 2007 Jun; 61(6):769-78. PubMed ID: 17151589
[TBL] [Abstract][Full Text] [Related]
15. Determining factors of the response to hyperhomocysteinemia treatment in renal transplant patients.
Díaz JM; Sainz Z; Gich I; Guirado LL; Puig T; Oliver A; Montañés R; Facundo C; Chuy E; Solà R
Transplant Proc; 2005 Nov; 37(9):3785-7. PubMed ID: 16386538
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis.
Woolf K; Manore MM
J Am Diet Assoc; 2008 Mar; 108(3):443-53; discussion 454. PubMed ID: 18313425
[TBL] [Abstract][Full Text] [Related]
18. [The effect of lowering plasma homocysteine levels on some parameters of thrombotic activity in haemodialyzed patients with chronic renal failure].
Kozłowska I
Ann Acad Med Stetin; 2004; 50(1):87-95. PubMed ID: 16871747
[TBL] [Abstract][Full Text] [Related]
19. Effect of folic acid and vitamins B6 and B12 on microcirculatory vasoreactivity in patients with hyperhomocysteinemia.
Abularrage CJ; Sidawy AN; White PW; Aidinian G; Dezee KJ; Weiswasser JM; Arora S
Vasc Endovascular Surg; 2007; 41(4):339-45. PubMed ID: 17704338
[TBL] [Abstract][Full Text] [Related]
20. Determinants of fasting total serum homocysteine levels in liver transplant recipients.
Akoglu B; Wondra K; Caspary WF; Faust D
Exp Clin Transplant; 2006 Jun; 4(1):462-6. PubMed ID: 16827644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
